Antiplatelet Therapy in Cardiovascular Disease (Q168211): Difference between revisions
From geokb
(Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1) |
(Changed an Item: moved OpenAlex ID to its dedicated external ID datatype for consistency) |
||
| Property / same as | |||
| Property / same as: https://openalex.org/T11064 / rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: T11064 / rank | |||
Normal rank | |||
Revision as of 12:28, 8 September 2024
Preventing cardiovascular events with medications that stop platelets from clotting.
- Aspirin
- Clopidogrel
- Ticagrelor
- Platelet Reactivity
- Cardiovascular Events
- Percutaneous Coronary Intervention
- Genetic Polymorphisms
- Bleeding Risk
- Thrombotic Events
- CYP2C19 Genotype
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiplatelet Therapy in Cardiovascular Disease |
Preventing cardiovascular events with medications that stop platelets from clotting. |
|
